Clinical trials
Recruiting Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
183 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 7 |
| 2022 | 18 |
| 2023 | 16 |
| 2024 | 25 |
| 2025 | 44 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 183 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 9 |
| M.D. Anderson Cancer Center | 5 |
| Monash University | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Princess Maxima Center for Pediatric Oncology | 4 |
| UNC Lineberger Comprehensive Cancer Center | 4 |
| Kura Oncology, Inc. | 3 |
| Massachusetts General Hospital | 3 |
| University Health Network, Toronto | 3 |
| University of Alabama at Birmingham | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 183 |
| Lymphoma | 59 |
| Leukemia, Myeloid, Acute | 46 |
| Hematologic Neoplasms | 32 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 30 |
| Myelodysplastic Syndromes | 26 |
| Neoplasms | 26 |
| Multiple Myeloma | 23 |
| Lymphoma, Non-Hodgkin | 16 |
| Neoplasms, Plasma Cell | 15 |
Trials
Showing 26 to 50 of 183. Each trial links to its page on Pharma Observatory.
83 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.